Downstream overdrive pacing and intracardiac concealed fusion to guide rapid identification of atrial tachycardia after atrial fibrillation ablation

• Published in: Europace (London, England) England), 2018-04, Vol.20 (4), p.596-603
• Main Authors: Barbhaiya, Chirag R, Baldinger, Samuel H, Kumar, Saurabh, Chinitz, Jason S, Enriquez, Alan D, John, Roy, Stevenson, William G, Michaud, Gregory F
• Format: Article
• Language: English
• Subjects: Action Potentials; Aged; Atrial Fibrillation - diagnosis; Atrial Fibrillation - physiopathology; Atrial Fibrillation - surgery; Cardiac Catheterization - instrumentation; Cardiac Catheters; Cardiac Pacing, Artificial; Catheter Ablation - adverse effects; Electrophysiologic Techniques, Cardiac - instrumentation; Female; Heart Rate; Humans; Male; Middle Aged; Pacemaker, Artificial; Predictive Value of Tests; Risk Factors; Tachycardia, Supraventricular - diagnosis; Tachycardia, Supraventricular - etiology; Tachycardia, Supraventricular - physiopathology; Treatment Outcome
• ISSN: 1099-5129; 1532-2092
• DOI: 10.1093/europace/euw405

Atrial tachycardia (AT) related to atrial fibrillation (AF) ablation frequently poses a diagnostic challenge. Downstream overdrive pacing (DOP) can be used to rapidly detect reentry and assess proximity of a pacing site to an AT circuit or focus. We hypothesized that systematic DOP using multielectrode catheters would facilitate AT mapping. DOP identified constant fusion when the post-pacing interval (PPI)-tachycardia cycle length (TCL) 75% of TCL. Mapping was performed as follows: (i) CS DOP, (ii) DOP at left atrial (LA) roof, (iii) DOP at selected LA sites based on prior DOP attempts, and (iv) mapping and ablation at regions of fractionated electrograms in region of AT. Activation mapping was performed at operator discretion. AT diagnosis was confirmed by successful ablation or additional mapping when ablation was unsuccessful. Fifty consecutive patients with sustained AT underwent mapping of 68 ATs, of whom 42 (62%) were macroreentrant, 19 were locally reentrant (28%), and 7 (10%) were focal. AT was correctly identified with a median of three DOP attempts. All macroreentrant ATs were identified with ≤6 DOP attempts. One AT (1.6%) was terminated by DOP, and three ATs (4.8%) required activation mapping. Intracardiac concealed fusion was seen in 26 ATs (38%), each of which was successfully ablated. Reentry could be demonstrated in a substantial majority of AF ablation-related AT. A stepwise diagnostic approach using DOP and recognition of intracardiac concealed fusion can be used to rapidly identify and ablate reentrant AT.